Versant Venture Capital VII, L.P.'s Net Worth

$27.9 Million

Who is Versant Venture Capital VII, L.P.?

Versant Venture Capital VII, L.P. has an estimated net worth of $27.9 Million. This is based on reported shares across multiple companies, which include CHINOOK THERAPEUTICS, INC., and RayzeBio, Inc..

SEC CIK

Versant Venture Capital VII, L.P.'s CIK is 0001750266

Past Insider Trading and Trends

2022 was Versant Venture Capital VII, L.P.'s most active year for acquiring shares with 2 total transactions. Versant Venture Capital VII, L.P.'s most active month to acquire stocks was the month of March. 2022 was Versant Venture Capital VII, L.P.'s most active year for disposing of shares, totalling 6 transactions. Versant Venture Capital VII, L.P.'s most active month to dispose stocks was the month of December. 2022 saw Versant Venture Capital VII, L.P. paying a total of $0.00 for 25,920 shares, this is the most they've acquired in one year. In 2022 Versant Venture Capital VII, L.P. cashed out on 1,735,873 shares for a total of $16,000,200.00, their largest year based on trade value.